AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Endoglim M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Arkas Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Endoglim M 1mg/500mg Tablet

Diabetic patients utilizing the dual-action formulation, GlycemiaControl 1mg/500mg tablets, benefit from its anti-diabetic properties. This adult-indicated combination medication manages type 2 diabetes mellitus by regulating blood glucose. Consistent daily ingestion, ideally with meals, at the same time, maximizes therapeutic effect. Dosage is determined and adjusted by your physician based on your blood glucose response. Discontinuation without medical supervision is strongly discouraged; it can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. GlycemiaControl is part of a comprehensive treatment plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Common side effects include hypoglycemia (low blood sugar). Learn to recognize symptoms—sweating, dizziness, headache, trembling—and carry a readily available fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. Contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before starting GlycemiaControl. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Endoglim M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Endoglim M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. It's recommended to take Endoglim M 1mg/500mg tablets with a meal.

Common Side effects of Endoglim M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Endoglim M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Endoglim M 1mg/500mg tablet should be administered with a meal.

How Endoglim M 1mg/500mg Tablet works:

Endoglim M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Endoglim M 1mg/500mg tablets with alcohol is contraindicated due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Endoglim M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Endoglim M 1mg/500mg tablets. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Endoglim M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. The medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Endoglim M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For individuals with mild to moderate liver disease, initiation with a reduced Endoglim M 1mg/500mg tablet dosage is typical; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Endoglim M 1mg/500mg Tablet :

Should you forget to take your Endoglim M 1mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Endoglim M 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Endoglim M 1mg/500mg Tablet

Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medicine. Prevent access by children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential side effect of Endoglim M 1mg/500mg tablets. Also known as Metformin-associated lactic acidosis (MALA), this rare complication poses a significant risk to individuals with impaired kidney function, the elderly, and those who consume excessive alcohol. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal discomfort, or bradycardia. Should any of these symptoms appear, discontinue Endoglim M 1mg/500mg tablet use and seek immediate medical attention.
The oral medication Endoglim M, a 1mg/500mg glimepiride and metformin combination tablet, manages type 2 diabetes mellitus in adults. Its effectiveness relies on concurrent dietary modifications and physical activity to regulate blood glucose. Glimepiride enhances pancreatic insulin secretion, while metformin reduces hepatic glucose production and improves insulin responsiveness. This dual-agent therapy is unsuitable for type 1 diabetes mellitus.
Endoglim M 1mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis may also occur. Prolonged administration can result in vitamin B12 deficiency.
Indeed, prolonged ingestion of Endoglim M 1mg/500mg Tablets can lead to Vitamin B12 insufficiency. This medication impedes Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications, such as paresthesia in the extremities, general weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental Vitamin B12 is recommended by some experts at least annually.
Indeed, Endoglim M 1mg/500mg Tablets may induce hypoglycemia. Low blood sugar can manifest as nausea, headache, irritability, hunger, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying readily available glucose, such as tablets, honey, or fruit juice, is advisable.
Consuming alcohol concurrently with Endoglim M 1mg/500mg tablets is inadvisable due to the risk of significantly reduced blood glucose, potentially causing hypoglycemia. Furthermore, this combination elevates the likelihood of lactic acidosis.
Endoglim M 1mg/500mg Tabl...
43
MRP 52
17% off